Személyre szabott medicina a kardiol ógiában

Translated title of the contribution: Personalised medicine in cardiology

Szelíd Zsolt László, P. Soós, Bagyura Zsolt, B. Merkely

Research output: Contribution to journalArticle

Abstract

Genetic variances may influence cardiovascular risk and have impact on response, side effects and possible toxicity of drugs used in cardiovascular medicine. Recently, population-based and multicenter cardiac studies provided increasing number of evidence on associations between genetic variances and clinical endpoints. Role of genotyping compared to dassic cardiovascular risk factors in cardiac risk evaluation is dearly increasing. There are also several studies focusing on associations between biological effects of cardiac drugs and relevant genotypes. Highlighted areas in this field indude 1) statins, 2) antiplatelet resistance, 3) effects of beta adrenergic receptor blockers, 4) ACE inhibitors, and 5) oral anticoagulats.

Original languageHungarian
Pages (from-to)111-114
Number of pages4
JournalOrvoskepzes
Volume86
Issue number2-3
Publication statusPublished - 2011

Fingerprint

Precision Medicine
Cardiology
Adrenergic beta-3 Receptor Antagonists
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Drug-Related Side Effects and Adverse Reactions
Angiotensin-Converting Enzyme Inhibitors
Multicenter Studies
Genotype
Medicine
Pharmaceutical Preparations
Population

ASJC Scopus subject areas

  • Medicine(all)

Cite this

László, S. Z., Soós, P., Zsolt, B., & Merkely, B. (2011). Személyre szabott medicina a kardiol ógiában. Orvoskepzes, 86(2-3), 111-114.

Személyre szabott medicina a kardiol ógiában. / László, Szelíd Zsolt; Soós, P.; Zsolt, Bagyura; Merkely, B.

In: Orvoskepzes, Vol. 86, No. 2-3, 2011, p. 111-114.

Research output: Contribution to journalArticle

László, SZ, Soós, P, Zsolt, B & Merkely, B 2011, 'Személyre szabott medicina a kardiol ógiában', Orvoskepzes, vol. 86, no. 2-3, pp. 111-114.
László, Szelíd Zsolt ; Soós, P. ; Zsolt, Bagyura ; Merkely, B. / Személyre szabott medicina a kardiol ógiában. In: Orvoskepzes. 2011 ; Vol. 86, No. 2-3. pp. 111-114.
@article{74f65939ecf34fb69a47cc72c1968a06,
title = "Szem{\'e}lyre szabott medicina a kardiol {\'o}gi{\'a}ban",
abstract = "Genetic variances may influence cardiovascular risk and have impact on response, side effects and possible toxicity of drugs used in cardiovascular medicine. Recently, population-based and multicenter cardiac studies provided increasing number of evidence on associations between genetic variances and clinical endpoints. Role of genotyping compared to dassic cardiovascular risk factors in cardiac risk evaluation is dearly increasing. There are also several studies focusing on associations between biological effects of cardiac drugs and relevant genotypes. Highlighted areas in this field indude 1) statins, 2) antiplatelet resistance, 3) effects of beta adrenergic receptor blockers, 4) ACE inhibitors, and 5) oral anticoagulats.",
keywords = "Personal based risk stratification, Pharmacogenomics",
author = "L{\'a}szl{\'o}, {Szel{\'i}d Zsolt} and P. So{\'o}s and Bagyura Zsolt and B. Merkely",
year = "2011",
language = "Hungarian",
volume = "86",
pages = "111--114",
journal = "Orvoskepzes",
issn = "0030-6037",
publisher = "Semmelweis Kiado",
number = "2-3",

}

TY - JOUR

T1 - Személyre szabott medicina a kardiol ógiában

AU - László, Szelíd Zsolt

AU - Soós, P.

AU - Zsolt, Bagyura

AU - Merkely, B.

PY - 2011

Y1 - 2011

N2 - Genetic variances may influence cardiovascular risk and have impact on response, side effects and possible toxicity of drugs used in cardiovascular medicine. Recently, population-based and multicenter cardiac studies provided increasing number of evidence on associations between genetic variances and clinical endpoints. Role of genotyping compared to dassic cardiovascular risk factors in cardiac risk evaluation is dearly increasing. There are also several studies focusing on associations between biological effects of cardiac drugs and relevant genotypes. Highlighted areas in this field indude 1) statins, 2) antiplatelet resistance, 3) effects of beta adrenergic receptor blockers, 4) ACE inhibitors, and 5) oral anticoagulats.

AB - Genetic variances may influence cardiovascular risk and have impact on response, side effects and possible toxicity of drugs used in cardiovascular medicine. Recently, population-based and multicenter cardiac studies provided increasing number of evidence on associations between genetic variances and clinical endpoints. Role of genotyping compared to dassic cardiovascular risk factors in cardiac risk evaluation is dearly increasing. There are also several studies focusing on associations between biological effects of cardiac drugs and relevant genotypes. Highlighted areas in this field indude 1) statins, 2) antiplatelet resistance, 3) effects of beta adrenergic receptor blockers, 4) ACE inhibitors, and 5) oral anticoagulats.

KW - Personal based risk stratification

KW - Pharmacogenomics

UR - http://www.scopus.com/inward/record.url?scp=82455174768&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=82455174768&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:82455174768

VL - 86

SP - 111

EP - 114

JO - Orvoskepzes

JF - Orvoskepzes

SN - 0030-6037

IS - 2-3

ER -